Global asset management company Affiliated Managers Group (AMG) has announced a $20 million matching gift to establish the Healey Center at Massachusetts General Hospital, the goal of which is to accelerate the development of amyotrophic lateral sclerosis (ALS) treatments. With this gift, which will fund over time,…
Search results for:
Depression and anxiety in amyotrophic lateral sclerosis (ALS) patients, even at low levels, are linked and should be addressed together, a study reports. Moreover, according to the study, support to caregivers is essential as the patient-caregiver relationship is of key importance in coping with ALS. The study, “Death…
Anelixis Therapeutics has begun dosing patients in the first human trial of its amyotrophic lateral sclerosis (ALS) treatment candidate, AT-1501, the company announced. The trial is currently enrolling both healthy volunteers and eight ALS patients to test AT-1501’s safety and tolerability. Researchers will also examine how the agent behaves…
An experimental gene therapy based on RNA interference (RNAi) shows potential to treat patients with familial amyotrophic lateral sclerosis (ALS) caused by mutations in the superoxide dismutase 1 (SOD1) gene, according to results of a preclinical study in nonhuman primates. The study, “Safe and effective superoxide…
The amount of time it takes to diagnose amyotrophic lateral sclerosis (ALS) and the use of Rilutek (riluzole) to treat it vary significantly across Canada, according to a new nationwide analysis of a patient registry. These findings highlight the need for future studies to identify the factors that contribute…
Amyotrophic lateral sclerosis (ALS) is a disease characterized by the progressive loss of the nerve cells that control muscle movement. There is currently no cure for the disease, but there are a number of treatments that can delay the progression of symptoms. Some…
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder in which nerve cells that control muscles gradually degrade. With disease progression, more and more muscles are affected, and it becomes challenging for patients to accomplish everyday tasks. The goal of occupational therapy is to help patients maintain their…
Amyotrophic lateral sclerosis (ALS) is a disease that leads to the progressive degeneration of nerve cells. Most patients experience some disability as a result of the disease and have difficulty with daily tasks like walking, feeding, and dressing. While there is no cure for ALS yet, there are a…
Amyotrophic lateral sclerosis (ALS) is a serious disorder that causes progressive loss of motor neurons, the nerve cells that control muscle movement. Most patients will experience some disability, including difficulty swallowing and slurred speech, as a result of the loss of these nerve cells. What is speech therapy? Speech therapy…
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder associated with the death of motor neurons. These are nerve cells that control the voluntary muscles, which are essential for movement. As the condition progresses, the muscles weaken and waste away, resulting in a loss of muscle control. Although ALS…